APA (7th ed.) Citation

Okudaira, N., Burt, H., & Mitra, A. (2024). Tipifarnib physiologically‐based pharmacokinetic modeling to assess drug–drug interaction, organ impairment, and biopharmaceutics in healthy subjects and cancer patients. CPT: pharmacometrics and systems pharmacology, 13(8), 1366-1379. https://doi.org/10.1002/psp4.13165

Chicago Style (17th ed.) Citation

Okudaira, Noriko, Howard Burt, and Amitava Mitra. "Tipifarnib Physiologically‐based Pharmacokinetic Modeling to Assess Drug–drug Interaction, Organ Impairment, and Biopharmaceutics in Healthy Subjects and Cancer Patients." CPT: Pharmacometrics and Systems Pharmacology 13, no. 8 (2024): 1366-1379. https://doi.org/10.1002/psp4.13165.

MLA (9th ed.) Citation

Okudaira, Noriko, et al. "Tipifarnib Physiologically‐based Pharmacokinetic Modeling to Assess Drug–drug Interaction, Organ Impairment, and Biopharmaceutics in Healthy Subjects and Cancer Patients." CPT: Pharmacometrics and Systems Pharmacology, vol. 13, no. 8, 2024, pp. 1366-1379, https://doi.org/10.1002/psp4.13165.